Previous 10 | Next 10 |
ProPhase Labs (PRPH) -23% after pricing equity offering.Neovasc (NVCN) -18%.Biohaven Pharmaceutical (BHVN) -13%.Yield10 Bioscience (YTEN) -12%.Technical Communications (TCCO) -10% after receiving delisting notice from Nasdaq.InVivo Therapeutics (NVIV) -8%.Lumentum Holdings (LIT...
WOBURN, Mass., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that Meghna Malik, Ph.D., Senior Director, will present at the 4 th CRISPR AgBio Congress which is being held December 1-3, 2020 as a virtual even...
The following slide deck was published by Yield10 Bioscience, Inc. in conjunction with their 2020 Q3 earnings call. For further details see: Yield10 Bioscience, Inc. 2020 Q3 - Results - Earnings Call Presentation
Yield10 Bioscience, Inc. (YTEN) Q3 2020 Earnings Conference Call Nov 12, 2020, 04:30 PM ET Company Participants Lynne Brum - VP, Planning and Corporate Communications Oliver Peoples - President and CEO Kristi Snell - VP, Research and Chief Science Officer Chuck Haaser - Chief Accounting Offic...
Yield10 Bioscience (YTEN): Q3 GAAP EPS of -$0.87 beats by $0.07.Revenue of $0.2M (-9.1% Y/Y) misses by $0.04M.Press Release For further details see: Yield10 Bioscience EPS beats by $0.07, misses on revenue
WOBURN, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three and nine months ended September 30, 2020. "We are very pleased with our strong progress across multiple fron...
WOBURN, Mass. and HARPENDEN, U.K., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced it has signed a collaboration agreement with UK-based Rothamsted Research to support Rothamsted’s Flagship Program to devel...
WOBURN, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN), an agricultural bioscience company, announced today that the Company will report its third quarter 2020 financial results and provide a corporate update on Thursday, November 12, 2020. Management...
WOBURN, Mass., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it has begun field testing to evaluate the emergence and agronomics of winter Camelina sativa varieties. The testing of these winter varietie...
WOBURN, Mass., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced it has completed the harvest for its 2020 Field Test Program for Camelina and canola trials conducted in the United States and Canada. Yield10’...
News, Short Squeeze, Breakout and More Instantly...
Yield10 Bioscience Inc. Company Name:
YTEN Stock Symbol:
NASDAQ Market:
- Nufarm to pay up to USD $5 million in consideration for the license -The parties will negotiate the sale of essentially all of Yield10’s assets to Nufarm WOBURN, Mass. and WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“...
WOBURN, Mass. and HARPENDEN, United Kingdom, June 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that U.K.-based Rothamsted Research Limited (“Rothamsted”)...
- EPA approved an amendment to the label of INTERLINE herbicide to include Camelina -The supplemental label now allows application of INTERLINE for over-the-top weed control in Camelina WOBURN, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield1...